Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Psychedelics, Psychosis, and Risk Reduction

Psychedelics, Psychosis, and Risk Reduction

FromBack from the Abyss: Psychiatry in Stories


Psychedelics, Psychosis, and Risk Reduction

FromBack from the Abyss: Psychiatry in Stories

ratings:
Length:
31 minutes
Released:
Oct 6, 2022
Format:
Podcast episode

Description

This is a talk that Dr. H gave in Denver at the Nowak Society in Aug. 2022. Medicalization and/or legalization of psilocybin is likely coming to Colorado soon, with other psychedelics soon to follow. This will foster both a new era of psychiatric treatments and psychospiritual exploration, as well as a significant increase in adverse psychiatric events, including psychotic breaks. Dr. H explores the various classes of psychedelics (cannabinoids, tryptamines, phenethylamines, ketamine, e.g.) and assesses their relative risk of triggering psychosis, how and why polypharmacy (particularly with THC) greatly magnifies risk of developing psychosis, and the complex interplay between genetic vulnerability for psychosis/schizophrenia and the use of various psychoactive drugs. BFTA on Instagram. @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/
Released:
Oct 6, 2022
Format:
Podcast episode

Titles in the series (100)

How do we find a way out of the darkest depths of despair? Psychiatrist Dr. Craig Heacock hosts a deep dive into powerfully moving stories of hope and healing, as well as topical explorations of psychopharmacology, psychotherapy, and psychedelics.